{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:34:20Z","timestamp":1793727260977,"version":"4.6.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R91"],"award-info":[{"award-number":["PNURSP2025R91"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.lfs.2025.123758","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T15:59:54Z","timestamp":1748015994000},"page":"123758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Omarigliptin ameliorates cisplatin-induced renal damage: Cross-talk between glucagon-like peptide-1, HMGB1\/RAGE\/TLR4 signaling, and TXNIP\/NLRP3 inflammasome\/gasdermin D axis"],"prefix":"10.1016","volume":"376","author":[{"given":"Shuruq E.","family":"Alsufyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany H.","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.K.","family":"El-Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Shaimaa A.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Fouad Hussein","family":"Hashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaly A.","family":"Abd Elmaaboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mennatallah A.","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Kabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2025.123758_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174985","article-title":"Rapid DNA interstrand cross-linking of Pt (IV) compound","volume":"925","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0015","first-page":"106","article-title":"Selected platinum complexes in standard and modern anti-cancer therapies","volume":"7","author":"Kopacz-Bednarska","year":"2022","journal-title":"Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2025.123758_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110504","article-title":"Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity","volume":"379","author":"Shin","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0030","article-title":"Protective effect of natural antioxidants on reducing cisplatin-induced nephrotoxicity","volume":"2022","author":"Zhou","year":"2022","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/toxres\/tfac019","article-title":"Mechanism of kidney injury induced by cisplatin","volume":"11","author":"Huang","year":"2022","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.lfs.2025.123758_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154415","article-title":"Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes","volume":"114","author":"Grespan","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.lfs.2025.123758_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106680","article-title":"Liraglutide abrogates nephrotoxic effects of chemotherapies","volume":"189","author":"Xu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"19","key":"10.1016\/j.lfs.2025.123758_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910822","article-title":"Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists","volume":"22","author":"Winiarska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123758_bb0060","series-title":"Augmented nephroprotective effect of liraglutide and rabeprazole via inhibition of OCT2 transporter in cisplatin-induced nephrotoxicity in rats","volume":"321","author":"Sharaf","year":"2023"},{"key":"10.1016\/j.lfs.2025.123758_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109801","article-title":"Novel insights into the augmented effect of curcumin and liraglutide in ameliorating cisplatin-induced nephrotoxicity in rats: effects on oxidative stress, inflammation, apoptosis and pyroptosis via GSK-3\u03b2","volume":"749","author":"El-Gohary","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2025.123758_bb0070","first-page":"197","volume":"15","author":"Skov","year":"2014","journal-title":"Effects of GLP-1 in the kidney."},{"issue":"14","key":"10.1016\/j.lfs.2025.123758_bb0075","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.7150\/thno.86831","article-title":"Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists","volume":"13","author":"Ghosh","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2025.123758_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.630962","article-title":"Liraglutide protects nucleus pulposus cells against high-glucose induced apoptosis by activating PI3K\/Akt\/mTOR\/Caspase-3 and PI3K\/Akt\/GSK3\u03b2\/Caspase-3 signaling pathways","volume":"8","author":"Yao","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.lfs.2025.123758_bb0085","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2165\/11591400-000000000-00000","article-title":"Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences","volume":"71","author":"Baetta","year":"2011","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.lfs.2025.123758_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/1735-5362.323920","article-title":"Anti-inflammatory effects of saxagliptin and vildagliptin against doxorubicin-induced nephrotoxicity in rats: attenuation of NLRP3 inflammasome up-regulation and tubulo-interstitial injury","volume":"16","author":"Mostafa","year":"2021","journal-title":"Res. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229377","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: a retrospective study","volume":"15","author":"Iwakura","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3803\/EnM.2020.912","article-title":"Comparative renal effects of dipeptidyl peptidase-4 inhibitors and sodium-glucose cotransporter 2 inhibitors on individual outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"36","author":"Bae","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2025.123758_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/11795514211051698","article-title":"Pleiotropic benefits of DPP-4 inhibitors beyond glycemic control","volume":"14","author":"Kang","year":"2021","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3803\/EnM.2023.1839","article-title":"Efficacy and safety of omarigliptin, a novel once-weekly dipeptidyl peptidase-4 inhibitor, in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"39","author":"Kamrul-Hasan","year":"2024","journal-title":"Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.lfs.2025.123758_bb0115","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/antiox11101940","article-title":"Omarigliptin mitigates 6-hydroxydopamine-or rotenone-induced oxidative toxicity in PC12 cells by antioxidant, anti-inflammatory, and anti-apoptotic actions","volume":"11","author":"Gouda","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0120","article-title":"A review of dipeptidyl peptidase-4 (DPP-4) and its potential synthetic derivatives in the management of diabetes mellitus","volume":"8","author":"Javed Naim","year":"2024","journal-title":"J. Angiother."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0125","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-151581","article-title":"Dipeptidyl Peptidase-4 inhibitors: a systematic review of structure-activity relationship studies","volume":"23","author":"Bayanati","year":"2024","journal-title":"Iranian Journal of Pharmaceutical Research: IJPR"},{"key":"10.1016\/j.lfs.2025.123758_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00210-020-01976-1","article-title":"Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats","volume":"394","author":"Al Za'abi","year":"2021","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0135","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1080\/21655979.2022.2055699","article-title":"Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/molecules26040889","article-title":"Repurposing of omarigliptin as a neuroprotective agent based on docking with A2A adenosine and AChE receptors, brain GLP-1 response and its brain\/plasma concentration ratio after 28 days multiple doses in rats using LC-MS\/MS","volume":"26","author":"Ayoub","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.lfs.2025.123758_bb0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"Journal of basic and clinical pharmacy"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030547","article-title":"Rosinidin flavonoid ameliorates hyperglycemia, lipid pathways and proinflammatory cytokines in streptozotocin-induced diabetic rats","volume":"14","author":"Gilani","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0165","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976"},{"issue":"10","key":"10.1016\/j.lfs.2025.123758_bb0170","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.3390\/ijms24109088","article-title":"Parkinson\u2019s disease: exploring different animal model systems","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0175","first-page":"520","article-title":"Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene-intoxicated mice","volume":"123","author":"Casini","year":"1986"},{"key":"10.1016\/j.lfs.2025.123758_bb0180","article-title":"Kidney ischaemia reperfusion injury in the rat: the EGTI scoring system as a valid and reliable tool for histological assessment","volume":"3","author":"Chavez","year":"2016"},{"key":"10.1016\/j.lfs.2025.123758_bb0185","first-page":"38","article-title":"Role of flavonoids in cisplatin-induced nephrotoxicity: an integrative review","author":"Costa Carioca","year":"2021","journal-title":"Journal of Morphological Sciences"},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cbdv.200800340","article-title":"Platinum\u2013DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes","volume":"7","author":"Ahmad","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.lfs.2025.123758_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116404","article-title":"Quantum chemistry calculation-aided discovery of potent small-molecule mimics of glutathione peroxidases for the treatment of cisplatin-induced hearing loss","volume":"271","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MNH.0000000000000080","article-title":"Dipeptidyl peptidase-4 inhibitors in progressive kidney disease","volume":"24","author":"Makino","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.lfs.2025.123758_bb0205","doi-asserted-by":"crossref","first-page":"F681","DOI":"10.1152\/ajprenal.00075.2012","article-title":"DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury","volume":"303","author":"Glorie","year":"2012","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"7","key":"10.1016\/j.lfs.2025.123758_bb0210","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1177\/1078155220901756","article-title":"Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin","volume":"26","author":"Ghadrdan","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"43","key":"10.1016\/j.lfs.2025.123758_bb0215","article-title":"Study the effect of Levosimendan in cisplatin-induced nephrotoxicity in experimental rats","volume":"1","author":"Mahmoud","year":"2022","journal-title":"Spec. Educ."},{"key":"10.1016\/j.lfs.2025.123758_bb0220","series-title":"Identification of Early Diagnostic and Predictive Biomarkers of Cisplatin-Induced Acute Kidney Injury Using Metabolomics","author":"Lim","year":"2023"},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.37990\/medr.1142424","article-title":"Biochemical and histopathological investigation of the protective effect of lutein in rat kidney exposed to cisplatin","volume":"4","author":"Bilgi\u00e7","year":"2022","journal-title":"Medical Records"},{"key":"10.1016\/j.lfs.2025.123758_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1349069","article-title":"Emerging role of antidiabetic drugs in cardiorenal protection","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123758_bb0235","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/antiox10091329","article-title":"Mitochondrial superoxide dismutase in cisplatin-induced kidney injury","volume":"10","author":"Mapuskar","year":"2021","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.lfs.2025.123758_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22914","article-title":"Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation","volume":"35","author":"Li","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"13","key":"10.1016\/j.lfs.2025.123758_bb0245","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3390\/ijms23137227","article-title":"Pro-inflammatory Signalling PRRopels cisplatin-induced toxicity","volume":"23","author":"Domingo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0255","article-title":"Protective effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, against cisplatin-induced nephrotoxicity in mice","volume":"2017","author":"Choi","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.lfs.2025.123758_bb0260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2007090982","article-title":"TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity","volume":"19","author":"Zhang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.lfs.2025.123758_bb0265","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1021\/acschemneuro.0c00537","article-title":"Omarigliptin mitigates lipopolysaccharide-induced neuroinflammation and dysfunction of the integrity of the blood\u2013brain barrier","volume":"11","author":"Du","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.21608\/ejmr.2022.222161","article-title":"Effect of Saxagliptin on cisplatin-induced nephrotoxicity in rats","volume":"3","author":"Attia","year":"2022","journal-title":"Egyptian Journal of Medical Research"},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0275","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1479164111434318","article-title":"Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease","volume":"9","author":"Sun","year":"2012","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000339028","article-title":"Renal and cardiac effects of DPP4 inhibitors\u2013from preclinical development to clinical research","volume":"36","author":"Hocher","year":"2013","journal-title":"Kidney Blood Press. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17925\/EE.2024.20.2.5","article-title":"New insights into the pleiotropic actions of dipeptidyl peptidase-4 inhibitors beyond glycaemic control","volume":"20","author":"Mangoura","year":"2024","journal-title":"touchREVIEWS in Endocrinology"},{"issue":"10","key":"10.1016\/j.lfs.2025.123758_bb0290","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00228-023-03541-0","article-title":"Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes","volume":"79","author":"Xie","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2025.123758_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120396","article-title":"Omarigliptin\/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt\/GSK-3\u03b2 signaling","volume":"295","author":"Kabel","year":"2022","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0305","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5115\/acb.2015.48.1.66","article-title":"Cisplatin induces primary necrosis through poly (ADP-ribose) polymerase 1 activation in kidney proximal tubular cells","volume":"48","author":"Park","year":"2015","journal-title":"Anatomy & cell biology"},{"key":"10.1016\/j.lfs.2025.123758_bb0310","series-title":"Advances in cancer research","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-420117-0.00001-3","article-title":"Reactive oxygen species in normal and tumor stem cells","author":"Zhou","year":"2014"},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0315","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.CPJ04005X","article-title":"Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury","volume":"97","author":"Yonekura","year":"2005","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123758_bb0320","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","article-title":"Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"270","author":"Soraci","year":"2023","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0325","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1210\/clinem\/dgae783","article-title":"Impact of DPP-4 inhibitors on interleukin levels in type 2 diabetes mellitus","volume":"110","author":"Feng","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"10.1016\/j.lfs.2025.123758_bb0330","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.3390\/molecules27217311","article-title":"Therapeutic potential of targeting the HMGB1\/RAGE axis in inflammatory diseases","volume":"27","author":"Singh","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0335","doi-asserted-by":"crossref","first-page":"F443","DOI":"10.1152\/ajprenal.00280.2019","article-title":"Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation","volume":"318","author":"Hviid","year":"2020","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"7","key":"10.1016\/j.lfs.2025.123758_bb0340","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","article-title":"Glucagon-like peptide 1 prevents reactive oxygen species\u2013induced endothelial cell senescence through the activation of protein kinase a","volume":"30","author":"Oeseburg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0345","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2022.2146512","article-title":"Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention","volume":"45","author":"Ma","year":"2023","journal-title":"Ren. Fail."},{"issue":"13","key":"10.1016\/j.lfs.2025.123758_bb0350","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.3390\/molecules26134100","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products","volume":"26","author":"Iksen","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2025.123758_bb0355","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.biopha.2018.06.088","article-title":"Berberine promoted myocardial protection of postoperative patients through regulating myocardial autophagy","volume":"105","author":"Qing","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.lfs.2025.123758_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22896","article-title":"Ginsenoside Rg3 attenuates cisplatin-induced kidney injury through inhibition of apoptosis and autophagy-inhibited NLRP3","volume":"35","author":"Zhai","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0365","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/1568009611313020008","article-title":"Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K\/AKT\/mTOR signaling","volume":"13","author":"Grunt, T","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.lfs.2025.123758_bb0370","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1080\/21655979.2021.1999366","article-title":"The effects of Omarigliptin on promoting osteoblastic differentiation","volume":"12","author":"Liao","year":"2021","journal-title":"Bioengineered"},{"issue":"4","key":"10.1016\/j.lfs.2025.123758_bb0375","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13205-021-02738-3","article-title":"Role of insulin receptor substance-1 modulating PI3K\/Akt insulin signaling pathway in Alzheimer's disease","volume":"11","author":"Zheng","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.lfs.2025.123758_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1430469","article-title":"Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents","volume":"15","author":"Dai","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123758_bb0385","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0390","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cbin.12258","article-title":"Carnosol alleviates cisplatin\u2013induced acute kidney injury by regulating apoptosis and pyroptosis","volume":"49","author":"Li","year":"2025","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2025.123758_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105789","article-title":"Vitamin D\/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3\/Caspase-1\/GSDMD pyroptosis pathway","volume":"206","author":"Jiang","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2025.123758_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110875","article-title":"Piperlongumine inhibits esophageal squamous cell carcinoma in vitro and in vivo by triggering NRF2\/ROS\/TXNIP\/NLRP3-dependent pyroptosis","volume":"390","author":"Cui","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0405","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/cimb45010021","article-title":"Transcriptomic analysis of the effect of metformin against cisplatin-induced ototoxicity: a potential mechanism of metformin-mediated inhibition of Thioredoxin-interacting protein (Txnip) gene expression","volume":"45","author":"Lee","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.07.001","article-title":"NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation","volume":"383","author":"Li","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0415","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1080\/21655979.2021.1957748","article-title":"Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase \u03b1 (AMPK\u03b1) in renal glomerular endothelial cells","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.lfs.2025.123758_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117026","article-title":"Omarigliptin\/rosinidin combination ameliorates cyclophosphamide-induced lung toxicity in rats: the interaction between glucagon-like peptide-1, TXNIP\/NLRP3 inflammasome signaling, and PI3K\/Akt\/FoxO1 axis","volume":"177","author":"Abd Elmaaboud","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2025.123758_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12020-016-1011-9","article-title":"Omarigliptin for the treatment of type 2 diabetes","volume":"54","author":"Tan","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.lfs.2025.123758_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117048","article-title":"Linagliptin mitigates cisplatin-induced kidney impairment via mitophagy regulation in rats, with emphasis on SIRT-3\/PGC-1\u03b1, PINK-1 and Parkin-2","volume":"491","author":"Ewees","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:58:11Z","timestamp":1749157091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525003935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":86,"alternative-id":["S0024320525003935"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123758","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omarigliptin ameliorates cisplatin-induced renal damage: Cross-talk between glucagon-like peptide-1, HMGB1\/RAGE\/TLR4 signaling, and TXNIP\/NLRP3 inflammasome\/gasdermin D axis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123758"}}